XML 19 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Information (Summary of Segment Perfomance Measures by Segment) (Detail) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Segment Reporting Information [Line Items]    
Net sales $ 133,500 $ 130,803
Gross profit 34,581 27,651
Income (loss) before income taxes 14,983 7,645
Operating Segments | Human Health    
Segment Reporting Information [Line Items]    
Net sales 57,481 49,079
Gross profit 20,309 14,541
Income (loss) before income taxes 10,503 5,457
Operating Segments | Pharmaceutical Ingredients    
Segment Reporting Information [Line Items]    
Net sales 38,360 37,977
Gross profit 6,114 6,150
Income (loss) before income taxes 2,099 1,533
Operating Segments | Performance Chemicals    
Segment Reporting Information [Line Items]    
Net sales 37,659 43,747
Gross profit 8,158 6,960
Income (loss) before income taxes $ 3,544 $ 1,924
Unallocated Corporate    
Segment Reporting Information [Line Items]    
Net sales
Gross profit
Income (loss) before income taxes $ (1,163) $ (1,269)